PD-L1 Expressions in Non-small Cell Lung Cancer and its Correlation with Imaging Findings

被引：0
|
作者：
Shigeta, N. [1 ]
Adachi, H. [1 ]
Ito, H. [1 ]
Isaka, T. [1 ]
Murakami, K. [1 ]
Miura, J. [1 ]
Kikunishi, N. [1 ]
Saito, H. [1 ]
Yokose, T. [1 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
non-small cell lung cancer; PD-L1; imaging features;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP06.02-03
引用
收藏
页码：S480 / S480
页数：1
相关论文
共 50 条
  • [21] Biomarkers of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Beyond PD-L1
    Cabezon-Gutierrez, Luis
    Custodio-Cabello, Sara
    Palka-Kotlowska, Magda
    Alonso-Viteri, Soledad
    Khosravi-Shahi, Parham
    CLINICAL LUNG CANCER, 2021, 22 (05) : 381 - 389
  • [22] Prognostic implication of PD-L1 polymorphisms in non-small cell lung cancer treated with radiotherapy
    Kang, Min Kyu
    Lee, Shin Yup
    Choi, Jin Eun
    Do, Sook Kyung
    Cho, Moon-June
    Kim, Jun-Sang
    Park, Jae Yong
    CANCER MEDICINE, 2021, 10 (22): : 8071 - 8078
  • [23] PD-L1 expression and its relationship with oncogenic drivers in non-small cell lung cancer (NSCLC)
    Jiang, Liyan
    Su, Xinying
    Zhang, Tianwei
    Yin, Xiaolu
    Zhang, Meizhuo
    Fu, Haihua
    Han, Hulin
    Sun, Yun
    Dong, Lili
    Qian, Jialin
    Xu, Yanhua
    Fu, Xuan
    Gavine, Paul R.
    Zhou, Yanbin
    Tian, Kun
    Huang, Jiaqi
    Shen, Dong
    Jiang, Haiyi
    Yao, Yihong
    Han, Baohui
    Gu, Yi
    ONCOTARGET, 2017, 8 (16) : 26845 - 26857
  • [24] Resistance to PD-1/PD-L1 immune checkpoint blockade in advanced non-small cell lung cancer
    Li, Lijun
    Pu, Haihong
    Zhang, Xiaoxin
    Guo, Xiaotian
    Li, Guangrui
    Zhang, Minghui
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 209
  • [25] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [26] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
    Gagne, Andreanne
    Wang, Emily
    Bastien, Nathalie
    Orain, Michele
    Desmeules, Patrice
    Page, Sylvain
    Trahan, Sylvain
    Couture, Christian
    Joubert, David
    Joubert, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
  • [27] PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
    Xiaodong Wu
    Yan Huang
    Qingping Zhao
    Lei Wang
    Xiao Song
    Yi Li
    Lei Jiang
    EJNMMI Research, 10
  • [28] The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related toxicity profile in non-small cell lung cancer
    Qian Zhu
    Hao Hu
    Li-Ying OuYang
    Rong Yang
    Wen-Xiao Wei
    Pin Huang
    Xin-Rong He
    BMC Cancer, 25 (1)
  • [29] PD-L1 expression correlation with metabolic parameters of FDG PET/CT and clinicopathological characteristics in non-small cell lung cancer
    Wu, Xiaodong
    Huang, Yan
    Zhao, Qingping
    Wang, Lei
    Song, Xiao
    Li, Yi
    Jiang, Lei
    EJNMMI RESEARCH, 2020, 10 (01)
  • [30] Clinicopathological correlation of PD-L1 and TET1 expression with tumor-infiltrating lymphocytes in non-small cell lung cancer
    Ahn, Hyein
    Lee, Hyun Ju
    Lee, Ji-Hye
    Cho, Hyun Deuk
    Oh, Mee-Hye
    Son, Ji Woong
    Jang, Si-Hyong
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
12345